	Parathyroidectomy
Vitamin D
Secondary hyperparathyroidism
Chronic renal failure
Calcium-phosphate product
	pediatric patients
PTH levels
bone disease
renal failure
normal range
phosphate
vitamin D analogue
hypercalcemia
dialysis
vitamin D
growth hormone
parathyroid hormone
intake
patients
Recommendation
growth
upper limit
calcium phosphorus product
clinical
risk
low
PTH
vitamin D metabolites
dialysis fluid
metabolic acidosis
children
higher
intermittent therapy
parathyroidectomy
plasma phosphate levels
doses
growth retardation
normal levels
level
adults
calcium
severe lesions
due
furosemide
increase
chronic
ability
assays
group
renal osteodystrophy

